You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-androgen receptor

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

Completed
  • Advanced Epithelial Ovarian
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Prostate Cancer Trial in Baltimore (Flutamide, Placebo)

Recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    SKCCC at Johns Hopkins
Sep 2, 2021

NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)

Not yet recruiting
  • NMDAR Autoimmune Encephalitis
  • LGI1 Autoimmune Encephalitis
  • Prague, Czechia
  • +1 more
Aug 15, 2022

COVID-19 Trial in Petach Tikva (no intervantion)

Active, not recruiting
  • COVID-19
  • no intervantion
  • Petach Tikva, Israel
    Schneider Children's Medical Center
Sep 29, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

Terminated
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)

Recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • ADT
  • Homewood, Alabama
  • +11 more
Jan 13, 2023

Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Micronized progesterone, Spironolactone, Placebo)

Recruiting
  • Hyperandrogenism
  • +2 more
  • Micronized progesterone
  • +2 more
  • Charlottesville, Virginia
    University of Virginia Clinical Research Unit
May 16, 2022

PCOS, Polycystic Ovary Syndrome Trial in Charlottesville (Micronized progesterone, Placebo, Flutamide)

Recruiting
  • PCOS
  • Polycystic Ovary Syndrome
  • Micronized progesterone
  • +3 more
  • Charlottesville, Virginia
    University of Virginia
May 16, 2022

Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)

Recruiting
  • Anti-NMDAR Encephalitis
  • Paris, France
    Hôpital Necker Enfants-Malades
Oct 31, 2022

Breast Cancer, Metastasis Trial in New York (Abemaciclib, Bicalutamide)

Recruiting
  • Breast Cancer
  • Metastasis
  • New York, New York
  • +2 more
Oct 14, 2021

Prostate Cancer Trial in Gainesville, Baltimore, Boston (LY2452473, Placebo)

Completed
Has Results
  • Prostate Cancer
  • Gainesville, Florida
  • +3 more
Sep 27, 2021

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Prostate Cancer, Stereotactic Body Radiation Therapy Trial (SBRT, STANDARD OF CARE)

Not yet recruiting
  • Prostate Cancer
  • Stereotactic Body Radiation Therapy
  • SBRT
  • STANDARD OF CARE
  • (no location specified)
Jan 25, 2022

Multiple Myeloma Trial in Orange, Sacramento, Oklahoma City (STI-1492)

Recruiting
  • Multiple Myeloma
  • STI-1492
  • Orange, California
  • +2 more
Jan 12, 2023

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Triple Negative Breast Cancer Trial (Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Seviteronel-D (Seivteronel in combination with dexamethasone)
  • Docetaxel
  • (no location specified)
Sep 21, 2021

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Aug 8, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia Trial in Beijing

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Autologous humanized anti-CD22 chimeric antigen receptor T cells
  • Beijing, Beijing, China
    Beijing Boren Hospital
Aug 12, 2022

Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,

Not yet recruiting
  • Idiopathic Inflammatory Myopathies
  • +3 more
  • (no location specified)
Nov 21, 2023

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Migraine Disorders, Chronic Migraine, Episodic Migraine Trial in Pavia (Monoclonal antibody targeting the CGRP pathway (ligand

Recruiting
  • Migraine Disorders
  • +2 more
  • Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)
  • Pavia, Italy
    Headache Science & Neurorehabilitation Center
Nov 23, 2023

Transgender Women Trial in Pathum Wan (Estradiol, Estradiol and Anti-Androgen, No intervention)

Completed
  • Transgender Women
  • Estradiol
  • +2 more
  • Pathum Wan, Bangkok, Thailand
    Faculty of Sports Science, Chulalongkorn University
Nov 2, 2023

OPTImal PALliative Anti-epidermal Growth Factor Receptor

Active, not recruiting
  • Colorectal Cancer Metastatic
  • +5 more
  • Plasma circulating DNA analysis
  • Aarhus, Denmark
    Aarhus University Hospital
Feb 24, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023